Global Tuberculosis Vaccine Treatment Market Growth 2021-2026
According to this latest study, the 2021 growth of Tuberculosis Vaccine Treatment will have significant change from previous year. By the most conservative estimates of global Tuberculosis Vaccine Treatment market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ 70 million in 2020. Over the next five years the Tuberculosis Vaccine Treatment market will register a 3.0% CAGR in terms of revenue, the global market size will reach US$ 79 million by 2026.
This report presents a comprehensive overview, market shares, and growth opportunities of Tuberculosis Vaccine Treatment market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2016 to 2021, in Section 2.3; and forecast to 2026 in section 11.7.
Immune Vaccine
Therapy Vaccine
Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 11.8.
Self-Procurement
UNICEF
Other
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in Chapter 3.
Merck
Japan BCG Lab
Serum Institute of India
AJ Vaccines
BioFarma
GreenSignal Bio Pharma
China National Biotec
Biomed Lublin
Taj Pharmaceuticals
Ataulpho de Paiva
IVAC
Queen Saovabha Mem. Inst
Microgen
Frequently Asked Questions
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
- By Type
- By Application
- By Region
- By Country
- By Manufacturer
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Tuberculosis Vaccine Treatment Consumption 2016-2026
2.1.2 Tuberculosis Vaccine Treatment Consumption CAGR by Region
2.2 Tuberculosis Vaccine Treatment Segment by Type
2.2.1 Immune Vaccine
2.2.2 Therapy Vaccine
2.3 Tuberculosis Vaccine Treatment Sales by Type
2.3.1 Global Tuberculosis Vaccine Treatment Sales Market Share by Type (2016-2021)
2.3.2 Global Tuberculosis Vaccine Treatment Revenue and Market Share by Type (2016-2021)
2.3.3 Global Tuberculosis Vaccine Treatment Sale Price by Type (2016-2021)
2.4 Tuberculosis Vaccine Treatment Segment by Application
2.4.1 Self-Procurement
2.4.2 UNICEF
2.4.3 Other
2.5 Tuberculosis Vaccine Treatment Sales by Application
2.5.1 Global Tuberculosis Vaccine Treatment Sale Market Share by Application (2016-2021)
2.5.2 Global Tuberculosis Vaccine Treatment Revenue and Market Share by Application (2016-2021)
2.5.3 Global Tuberculosis Vaccine Treatment Sale Price by Application (2016-2021)
3 Global Tuberculosis Vaccine Treatment by Company
3.1 Global Tuberculosis Vaccine Treatment Sales Market Share by Company
3.1.1 Global Tuberculosis Vaccine Treatment Sales by Company (2019-2021)
3.1.2 Global Tuberculosis Vaccine Treatment Sales Market Share by Company (2019-2021)
3.2 Global Tuberculosis Vaccine Treatment Revenue Market Share by Company
3.2.1 Global Tuberculosis Vaccine Treatment Revenue by Company (2019-2021)
3.2.2 Global Tuberculosis Vaccine Treatment Revenue Market Share by Company (2019-2021)
3.3 Global Tuberculosis Vaccine Treatment Sale Price by Company
3.4 Global Manufacturers Tuberculosis Vaccine Treatment Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Tuberculosis Vaccine Treatment Product Location Distribution
3.4.2 Players Tuberculosis Vaccine Treatment Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 Tuberculosis Vaccine Treatment by Region
4.1 Global Tuberculosis Vaccine Treatment by Region
4.1.1 Global Tuberculosis Vaccine Treatment Sales by Region
4.1.2 Global Tuberculosis Vaccine Treatment Revenue by Region
4.2 Americas Tuberculosis Vaccine Treatment Sales Growth
4.3 APAC Tuberculosis Vaccine Treatment Sales Growth
4.4 Europe Tuberculosis Vaccine Treatment Sales Growth
4.5 Middle East & Africa Tuberculosis Vaccine Treatment Sales Growth
5 Americas
5.1 Americas Tuberculosis Vaccine Treatment Sales by Country
5.1.1 Americas Tuberculosis Vaccine Treatment Sales by Country (2016-2021)
5.1.2 Americas Tuberculosis Vaccine Treatment Revenue by Country (2016-2021)
5.2 Americas Tuberculosis Vaccine Treatment Sales by Type
5.3 Americas Tuberculosis Vaccine Treatment Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Tuberculosis Vaccine Treatment Sales by Region
6.1.1 APAC Tuberculosis Vaccine Treatment Sales by Region (2016-2021)
6.1.2 APAC Tuberculosis Vaccine Treatment Revenue by Region (2016-2021)
6.2 APAC Tuberculosis Vaccine Treatment Sales by Type
6.3 APAC Tuberculosis Vaccine Treatment Sales by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Tuberculosis Vaccine Treatment by Country
7.1.1 Europe Tuberculosis Vaccine Treatment Sales by Country (2016-2021)
7.1.2 Europe Tuberculosis Vaccine Treatment Revenue by Country (2016-2021)
7.2 Europe Tuberculosis Vaccine Treatment Sales by Type
7.3 Europe Tuberculosis Vaccine Treatment Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Tuberculosis Vaccine Treatment by Country
8.1.1 Middle East & Africa Tuberculosis Vaccine Treatment Sales by Country (2016-2021)
8.1.2 Middle East & Africa Tuberculosis Vaccine Treatment Revenue by Country (2016-2021)
8.2 Middle East & Africa Tuberculosis Vaccine Treatment Sales by Type
8.3 Middle East & Africa Tuberculosis Vaccine Treatment Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Country
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Tuberculosis Vaccine Treatment Distributors
10.3 Tuberculosis Vaccine Treatment Customer
11 Global Tuberculosis Vaccine Treatment Market Forecast
11.1 Global Tuberculosis Vaccine Treatment Forecast by Region
11.1.1 Global Tuberculosis Vaccine Treatment Forecast by Regions (2021-2026)
11.2.2 Global Tuberculosis Vaccine Treatment Revenue Forecast by Regions (2021-2026)
11.2 Americas Forecast by Country
11.3 APAC Forecast by Region
11.4 Europe Forecast by Country
11.5 Middle East & Africa Forecast by Country
11.6 Global Tuberculosis Vaccine Treatment Forecast by Type
11.7 Global Tuberculosis Vaccine Treatment Forecast by Application
12 Key Players Analysis
12.1 Merck
12.1.1 Merck Company Information
12.1.2 Merck Tuberculosis Vaccine Treatment Product Offered
12.1.3 Merck Tuberculosis Vaccine Treatment Sales, Revenue, Price and Gross Margin (2019-2021)
12.1.4 Merck Main Business Overview
12.1.5 Merck Latest Developments
12.2 Japan BCG Lab
12.2.1 Japan BCG Lab Company Information
12.2.2 Japan BCG Lab Tuberculosis Vaccine Treatment Product Offered
12.2.3 Japan BCG Lab Tuberculosis Vaccine Treatment Sales, Revenue, Price and Gross Margin (2019-2021)
12.2.4 Japan BCG Lab Main Business Overview
12.2.5 Japan BCG Lab Latest Developments
12.3 Serum Institute of India
12.3.1 Serum Institute of India Company Information
12.3.2 Serum Institute of India Tuberculosis Vaccine Treatment Product Offered
12.3.3 Serum Institute of India Tuberculosis Vaccine Treatment Sales, Revenue, Price and Gross Margin (2019-2021)
12.3.4 Serum Institute of India Main Business Overview
12.3.5 Serum Institute of India Latest Developments
12.4 AJ Vaccines
12.4.1 AJ Vaccines Company Information
12.4.2 AJ Vaccines Tuberculosis Vaccine Treatment Product Offered
12.4.3 AJ Vaccines Tuberculosis Vaccine Treatment Sales, Revenue, Price and Gross Margin (2019-2021)
12.4.4 AJ Vaccines Main Business Overview
12.4.5 AJ Vaccines Latest Developments
12.5 BioFarma
12.5.1 BioFarma Company Information
12.5.2 BioFarma Tuberculosis Vaccine Treatment Product Offered
12.5.3 BioFarma Tuberculosis Vaccine Treatment Sales, Revenue, Price and Gross Margin (2019-2021)
12.5.4 BioFarma Main Business Overview
12.5.5 BioFarma Latest Developments
12.6 GreenSignal Bio Pharma
12.6.1 GreenSignal Bio Pharma Company Information
12.6.2 GreenSignal Bio Pharma Tuberculosis Vaccine Treatment Product Offered
12.6.3 GreenSignal Bio Pharma Tuberculosis Vaccine Treatment Sales, Revenue, Price and Gross Margin (2019-2021)
12.6.4 GreenSignal Bio Pharma Main Business Overview
12.6.5 GreenSignal Bio Pharma Latest Developments
12.7 China National Biotec
12.7.1 China National Biotec Company Information
12.7.2 China National Biotec Tuberculosis Vaccine Treatment Product Offered
12.7.3 China National Biotec Tuberculosis Vaccine Treatment Sales, Revenue, Price and Gross Margin (2019-2021)
12.7.4 China National Biotec Main Business Overview
12.7.5 China National Biotec Latest Developments
12.8 Biomed Lublin
12.8.1 Biomed Lublin Company Information
12.8.2 Biomed Lublin Tuberculosis Vaccine Treatment Product Offered
12.8.3 Biomed Lublin Tuberculosis Vaccine Treatment Sales, Revenue, Price and Gross Margin (2019-2021)
12.8.4 Biomed Lublin Main Business Overview
12.8.5 Biomed Lublin Latest Developments
12.9 Taj Pharmaceuticals
12.9.1 Taj Pharmaceuticals Company Information
12.9.2 Taj Pharmaceuticals Tuberculosis Vaccine Treatment Product Offered
12.9.3 Taj Pharmaceuticals Tuberculosis Vaccine Treatment Sales, Revenue, Price and Gross Margin (2019-2021)
12.9.4 Taj Pharmaceuticals Main Business Overview
12.9.5 Taj Pharmaceuticals Latest Developments
12.10 Ataulpho de Paiva
12.10.1 Ataulpho de Paiva Company Information
12.10.2 Ataulpho de Paiva Tuberculosis Vaccine Treatment Product Offered
12.10.3 Ataulpho de Paiva Tuberculosis Vaccine Treatment Sales, Revenue, Price and Gross Margin (2019-2021)
12.10.4 Ataulpho de Paiva Main Business Overview
12.10.5 Ataulpho de Paiva Latest Developments
12.11 IVAC
12.11.1 IVAC Company Information
12.11.2 IVAC Tuberculosis Vaccine Treatment Product Offered
12.11.3 IVAC Tuberculosis Vaccine Treatment Sales, Revenue, Price and Gross Margin (2019-2021)
12.11.4 IVAC Main Business Overview
12.11.5 IVAC Latest Developments
12.12 Queen Saovabha Mem. Inst
12.12.1 Queen Saovabha Mem. Inst Company Information
12.12.2 Queen Saovabha Mem. Inst Tuberculosis Vaccine Treatment Product Offered
12.12.3 Queen Saovabha Mem. Inst Tuberculosis Vaccine Treatment Sales, Revenue, Price and Gross Margin (2019-2021)
12.12.4 Queen Saovabha Mem. Inst Main Business Overview
12.12.5 Queen Saovabha Mem. Inst Latest Developments
12.13 Microgen
12.13.1 Microgen Company Information
12.13.2 Microgen Tuberculosis Vaccine Treatment Product Offered
12.13.3 Microgen Tuberculosis Vaccine Treatment Sales, Revenue, Price and Gross Margin (2019-2021)
12.13.4 Microgen Main Business Overview
12.13.5 Microgen Latest Developments
13 Research Findings and Conclusion
List of Tables
Table 1. Tuberculosis Vaccine Treatment Consumption CAGR by Region (2020-2026) & ($ Millions)
Table 2. Major Players of Immune Vaccine
Table 3. Major Players of Therapy Vaccine
Table 4. Global Tuberculosis Vaccine Treatment Sales by Type (2016-2021) & (K Dose)
Table 5. Global Tuberculosis Vaccine Treatment Sales Market Share by Type (2016-2021)
Table 6. Global Tuberculosis Vaccine Treatment Revenue by Type (2016-2021) & ($ million)
Table 7. Global Tuberculosis Vaccine Treatment Revenue Market Share by Type (2016-2021)
Table 8. Global Tuberculosis Vaccine Treatment Sale Price by Type (2016-2021)
Table 9. Global Tuberculosis Vaccine Treatment Sales by Application (2016-2021) & (K Dose)
Table 10. Global Tuberculosis Vaccine Treatment Sales Market Share by Application (2016-2021)
Table 11. Global Tuberculosis Vaccine Treatment Value by Application (2016-2021)
Table 12. Global Tuberculosis Vaccine Treatment Revenue Market Share by Application (2016-2021)
Table 13. Global Tuberculosis Vaccine Treatment Sale Price by Application (2016-2021)
Table 14. Global Tuberculosis Vaccine Treatment Sales by Company (2019-2021) & (K Dose)
Table 15. Global Tuberculosis Vaccine Treatment Sales Market Share by Company (2019-2021)
Table 16. Global Tuberculosis Vaccine Treatment Revenue by Company (2019-2021) ($ Millions)
Table 17. Global Tuberculosis Vaccine Treatment Revenue Market Share by Company (2019-2021)
Table 18. Global Tuberculosis Vaccine Treatment Sale Price by Company (2019-2021)
Table 19. Key Manufacturers Tuberculosis Vaccine Treatment Producing Area Distribution and Sales Area
Table 20. Players Tuberculosis Vaccine Treatment Products Offered
Table 21. Tuberculosis Vaccine Treatment Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
Table 22. New Products and Potential Entrants
Table 23. Mergers & Acquisitions, Expansion
Table 24. Global Tuberculosis Vaccine Treatment Sales by Region (2016-2021) (K Dose)
Table 25. Global Tuberculosis Vaccine Treatment Sales Market Share by Region (2016-2021)
Table 26. Global Tuberculosis Vaccine Treatment Revenue by Region (2016-2021) & ($ Millions)
Table 27. Global Tuberculosis Vaccine Treatment Revenue Market Share by Region (2016-2021)
Table 28. Americas Tuberculosis Vaccine Treatment Sales by Country (2016-2021) & (K Dose)
Table 29. Americas Tuberculosis Vaccine Treatment Sales Market Share by Country (2016-2021)
Table 30. Americas Tuberculosis Vaccine Treatment Revenue by Country (2016-2021) & ($ Millions)
Table 31. Americas Tuberculosis Vaccine Treatment Revenue Market Share by Country (2016-2021)
Table 32. Americas Tuberculosis Vaccine Treatment Sales by Type (2016-2021) & (K Dose)
Table 33. Americas Tuberculosis Vaccine Treatment Sales Market Share by Type (2016-2021)
Table 34. Americas Tuberculosis Vaccine Treatment Sales by Application (2016-2021) & (K Dose)
Table 35. Americas Tuberculosis Vaccine Treatment Sales Market Share by Application (2016-2021)
Table 36. APAC Tuberculosis Vaccine Treatment Sales by Region (2016-2021) & (K Dose)
Table 37. APAC Tuberculosis Vaccine Treatment Sales Market Share by Region (2016-2021)
Table 38. APAC Tuberculosis Vaccine Treatment Revenue by Region (2016-2021) & ($ Millions)
Table 39. APAC Tuberculosis Vaccine Treatment Revenue Market Share by Region (2016-2021)
Table 40. APAC Tuberculosis Vaccine Treatment Sales by Type (2016-2021) & (K Dose)
Table 41. APAC Tuberculosis Vaccine Treatment Sales Market Share by Type (2016-2021)
Table 42. APAC Tuberculosis Vaccine Treatment Sales by Application (2016-2021) & (K Dose)
Table 43. APAC Tuberculosis Vaccine Treatment Sales Market Share by Application (2016-2021)
Table 44. Europe Tuberculosis Vaccine Treatment Sales by Country (2016-2021) & (K Dose)
Table 45. Europe Tuberculosis Vaccine Treatment Sales Market Share by Country (2016-2021)
Table 46. Europe Tuberculosis Vaccine Treatment Revenue by Country (2016-2021) & ($ Millions)
Table 47. Europe Tuberculosis Vaccine Treatment Revenue Market Share by Country (2016-2021)
Table 48. Europe Tuberculosis Vaccine Treatment Sales by Type (2016-2021) & (K Dose)
Table 49. Europe Tuberculosis Vaccine Treatment Sales Market Share by Type (2016-2021)
Table 50. Europe Tuberculosis Vaccine Treatment Sales by Application (2016-2021) & (K Dose)
Table 51. Europe Tuberculosis Vaccine Treatment Sales Market Share by Application (2016-2021)
Table 52. Middle East & Africa Tuberculosis Vaccine Treatment Sales by Country (2016-2021) & (K Dose)
Table 53. Middle East & Africa Tuberculosis Vaccine Treatment Sales Market Share by Country (2016-2021)
Table 54. Middle East & Africa Tuberculosis Vaccine Treatment Revenue by Country (2016-2021) & ($ Millions)
Table 55. Middle East & Africa Tuberculosis Vaccine Treatment Revenue Market Share by Country (2016-2021)
Table 56. Middle East & Africa Tuberculosis Vaccine Treatment Sales by Type (2016-2021) & (K Dose)
Table 57. Middle East & Africa Tuberculosis Vaccine Treatment Sales Market Share by Type (2016-2021)
Table 58. Middle East & Africa Tuberculosis Vaccine Treatment Sales by Application (2016-2021) & (K Dose)
Table 59. Middle East & Africa Tuberculosis Vaccine Treatment Sales Market Share by Application (2016-2021)
Table 60. Key and Potential Regions of Tuberculosis Vaccine Treatment
Table 61. Key Application and Potential Industries of Tuberculosis Vaccine Treatment
Table 62. Key Challenges of Tuberculosis Vaccine Treatment
Table 63. Key Trends of Tuberculosis Vaccine Treatment
Table 64. Tuberculosis Vaccine Treatment Distributors List
Table 65. Tuberculosis Vaccine Treatment Customer List
Table 66. Global Tuberculosis Vaccine Treatment Sales Forecast by Region (2021-2026) & (K Dose)
Table 67. Global Tuberculosis Vaccine Treatment Consumption Market Forecast by Region
Table 68. Global Tuberculosis Vaccine Treatment Revenue Forecast by Region (2021-2026) & ($ millions)
Table 69. Global Tuberculosis Vaccine Treatment Revenue Market Share Forecast by Region (2021-2026)
Table 70. Americas Tuberculosis Vaccine Treatment Sales Forecast by Country (2021-2026) & (K Dose)
Table 71. Americas Tuberculosis Vaccine Treatment Revenue Forecast by Country (2021-2026) & ($ millions)
Table 72. APAC Tuberculosis Vaccine Treatment Sales Forecast by Region (2021-2026) & (K Dose)
Table 73. APAC Tuberculosis Vaccine Treatment Revenue Forecast by Region (2021-2026) & ($ millions)
Table 74. Europe Tuberculosis Vaccine Treatment Sales Forecast by Country (2021-2026) & (K Dose)
Table 75. Europe Tuberculosis Vaccine Treatment Revenue Forecast by Country (2021-2026) & ($ millions)
Table 76. Middle East & Africa Tuberculosis Vaccine Treatment Sales Forecast by Country (2021-2026) & (K Dose)
Table 77. Middle East & Africa Tuberculosis Vaccine Treatment Revenue Forecast by Country (2021-2026) & ($ millions)
Table 78. Global Tuberculosis Vaccine Treatment Sales Forecast by Type (2021-2026) & (K Dose)
Table 79. Global Tuberculosis Vaccine Treatment Sales Market Share Forecast by Type (2021-2026)
Table 80. Global Tuberculosis Vaccine Treatment Revenue Forecast by Type (2021-2026) & ($ Millions)
Table 81. Global Tuberculosis Vaccine Treatment Revenue Market Share Forecast by Type (2021-2026)
Table 82. Global Tuberculosis Vaccine Treatment Sales Forecast by Application (2021-2026) & (K Dose)
Table 83. Global Tuberculosis Vaccine Treatment Sales Market Share Forecast by Application (2021-2026)
Table 84. Global Tuberculosis Vaccine Treatment Revenue Forecast by Application (2021-2026) & ($ Millions)
Table 85. Global Tuberculosis Vaccine Treatment Revenue Market Share Forecast by Application (2021-2026)
Table 86. Merck Basic Information, Tuberculosis Vaccine Treatment Manufacturing Base, Sales Area and Its Competitors
Table 87. Merck Tuberculosis Vaccine Treatment Product Offered
Table 88. Merck Tuberculosis Vaccine Treatment Sales (K Dose), Revenue ($ Million), Price (USD/K Dose) and Gross Margin (2019-2021E)
Table 89. Merck Main Business
Table 90. Merck Latest Developments
Table 91. Japan BCG Lab Basic Information, Tuberculosis Vaccine Treatment Manufacturing Base, Sales Area and Its Competitors
Table 92. Japan BCG Lab Tuberculosis Vaccine Treatment Product Offered
Table 93. Japan BCG Lab Tuberculosis Vaccine Treatment Sales (K Dose), Revenue ($ Million), Price (USD/K Dose) and Gross Margin (2019-2021E)
Table 94. Japan BCG Lab Main Business
Table 95. Japan BCG Lab Latest Developments
Table 96. Serum Institute of India Basic Information, Tuberculosis Vaccine Treatment Manufacturing Base, Sales Area and Its Competitors
Table 97. Serum Institute of India Tuberculosis Vaccine Treatment Product Offered
Table 98. Serum Institute of India Tuberculosis Vaccine Treatment Sales (K Dose), Revenue ($ Million), Price (USD/K Dose) and Gross Margin (2019-2021E)
Table 99. Serum Institute of India Main Business
Table 100. Serum Institute of India Latest Developments
Table 101. AJ Vaccines Basic Information, Tuberculosis Vaccine Treatment Manufacturing Base, Sales Area and Its Competitors
Table 102. AJ Vaccines Tuberculosis Vaccine Treatment Product Offered
Table 103. AJ Vaccines Tuberculosis Vaccine Treatment Sales (K Dose), Revenue ($ Million), Price (USD/K Dose) and Gross Margin (2019-2021E)
Table 104. AJ Vaccines Main Business
Table 105. AJ Vaccines Latest Developments
Table 106. BioFarma Basic Information, Tuberculosis Vaccine Treatment Manufacturing Base, Sales Area and Its Competitors
Table 107. BioFarma Tuberculosis Vaccine Treatment Product Offered
Table 108. BioFarma Tuberculosis Vaccine Treatment Sales (K Dose), Revenue ($ Million), Price (USD/K Dose) and Gross Margin (2019-2021E)
Table 109. BioFarma Main Business
Table 110. BioFarma Latest Developments
Table 111. GreenSignal Bio Pharma Basic Information, Tuberculosis Vaccine Treatment Manufacturing Base, Sales Area and Its Competitors
Table 112. GreenSignal Bio Pharma Tuberculosis Vaccine Treatment Product Offered
Table 113. GreenSignal Bio Pharma Tuberculosis Vaccine Treatment Sales (K Dose), Revenue ($ Million), Price (USD/K Dose) and Gross Margin (2019-2021E)
Table 114. GreenSignal Bio Pharma Main Business
Table 115. GreenSignal Bio Pharma Latest Developments
Table 116. China National Biotec Basic Information, Tuberculosis Vaccine Treatment Manufacturing Base, Sales Area and Its Competitors
Table 117. China National Biotec Tuberculosis Vaccine Treatment Product Offered
Table 118. China National Biotec Tuberculosis Vaccine Treatment Sales (K Dose), Revenue ($ Million), Price (USD/K Dose) and Gross Margin (2019-2021E)
Table 119. China National Biotec Main Business
Table 120. China National Biotec Latest Developments
Table 121. Biomed Lublin Basic Information, Tuberculosis Vaccine Treatment Manufacturing Base, Sales Area and Its Competitors
Table 122. Biomed Lublin Tuberculosis Vaccine Treatment Product Offered
Table 123. Biomed Lublin Tuberculosis Vaccine Treatment Sales (K Dose), Revenue ($ Million), Price (USD/K Dose) and Gross Margin (2019-2021E)
Table 124. Biomed Lublin Main Business
Table 125. Biomed Lublin Latest Developments
Table 126. Taj Pharmaceuticals Basic Information, Tuberculosis Vaccine Treatment Manufacturing Base, Sales Area and Its Competitors
Table 127. Taj Pharmaceuticals Tuberculosis Vaccine Treatment Product Offered
Table 128. Taj Pharmaceuticals Tuberculosis Vaccine Treatment Sales (K Dose), Revenue ($ Million), Price (USD/K Dose) and Gross Margin (2019-2021E)
Table 129. Taj Pharmaceuticals Main Business
Table 130. Taj Pharmaceuticals Latest Developments
Table 131. Ataulpho de Paiva Basic Information, Tuberculosis Vaccine Treatment Manufacturing Base, Sales Area and Its Competitors
Table 132. Ataulpho de Paiva Tuberculosis Vaccine Treatment Product Offered
Table 133. Ataulpho de Paiva Tuberculosis Vaccine Treatment Sales (K Dose), Revenue ($ Million), Price (USD/K Dose) and Gross Margin (2019-2021E)
Table 134. Ataulpho de Paiva Main Business
Table 135. Ataulpho de Paiva Latest Developments
Table 136. IVAC Basic Information, Tuberculosis Vaccine Treatment Manufacturing Base, Sales Area and Its Competitors
Table 137. IVAC Tuberculosis Vaccine Treatment Product Offered
Table 138. IVAC Tuberculosis Vaccine Treatment Sales (K Dose), Revenue ($ Million), Price (USD/K Dose) and Gross Margin (2019-2021E)
Table 139. IVAC Main Business
Table 140. IVAC Latest Developments
Table 141. Queen Saovabha Mem. Inst Basic Information, Tuberculosis Vaccine Treatment Manufacturing Base, Sales Area and Its Competitors
Table 142. Queen Saovabha Mem. Inst Tuberculosis Vaccine Treatment Product Offered
Table 143. Queen Saovabha Mem. Inst Tuberculosis Vaccine Treatment Sales (K Dose), Revenue ($ Million), Price (USD/K Dose) and Gross Margin (2019-2021E)
Table 144. Queen Saovabha Mem. Inst Main Business
Table 145. Queen Saovabha Mem. Inst Latest Developments
Table 146. Microgen Basic Information, Tuberculosis Vaccine Treatment Manufacturing Base, Sales Area and Its Competitors
Table 147. Microgen Tuberculosis Vaccine Treatment Product Offered
Table 148. Microgen Tuberculosis Vaccine Treatment Sales (K Dose), Revenue ($ Million), Price (USD/K Dose) and Gross Margin (2019-2021E)
Table 149. Microgen Main Business
Table 150. Microgen Latest Developments
List of Figures
Figure 1. Picture of Tuberculosis Vaccine Treatment
Figure 2. Tuberculosis Vaccine Treatment Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Tuberculosis Vaccine Treatment Sales Growth Rate 2016-2026 (K Dose)
Figure 7. Global Tuberculosis Vaccine Treatment Revenue Growth Rate 2016-2026 ($ Millions)
Figure 8. Tuberculosis Vaccine Treatment Sales by Region (2021 & 2026) & ($ millions)
Figure 9. Product Picture of Immune Vaccine
Figure 10. Product Picture of Therapy Vaccine
Figure 11. Global Tuberculosis Vaccine Treatment Sales Market Share by Type in 2020
Figure 12. Global Tuberculosis Vaccine Treatment Revenue Market Share by Type (2016-2021)
Figure 13. Tuberculosis Vaccine Treatment Consumed in Self-Procurement
Figure 14. Global Tuberculosis Vaccine Treatment Market: Self-Procurement (2016-2021) & (K Dose)
Figure 15. Tuberculosis Vaccine Treatment Consumed in UNICEF
Figure 16. Global Tuberculosis Vaccine Treatment Market: UNICEF (2016-2021) & (K Dose)
Figure 17. Tuberculosis Vaccine Treatment Consumed in Other
Figure 18. Global Tuberculosis Vaccine Treatment Market: Other (2016-2021) & (K Dose)
Figure 19. Global Tuberculosis Vaccine Treatment Sales Market Share by Application (2016-2021)
Figure 20. Global Tuberculosis Vaccine Treatment Revenue Market Share by Application in 2020
Figure 21. Tuberculosis Vaccine Treatment Revenue Market by Company in 2020 ($ Million)
Figure 22. Global Tuberculosis Vaccine Treatment Revenue Market Share by Company in 2020
Figure 23. Global Tuberculosis Vaccine Treatment Sales Market Share by Regions (2016-2021)
Figure 24. Global Tuberculosis Vaccine Treatment Revenue Market Share by Region in 2020
Figure 25. Americas Tuberculosis Vaccine Treatment Sales 2016-2021 (K Dose)
Figure 26. Americas Tuberculosis Vaccine Treatment Revenue 2016-2021 ($ Millions)
Figure 27. APAC Tuberculosis Vaccine Treatment Sales 2016-2021 (K Dose)
Figure 28. APAC Tuberculosis Vaccine Treatment Revenue 2016-2021 ($ Millions)
Figure 29. Europe Tuberculosis Vaccine Treatment Sales 2016-2021 (K Dose)
Figure 30. Europe Tuberculosis Vaccine Treatment Revenue 2016-2021 ($ Millions)
Figure 31. Middle East & Africa Tuberculosis Vaccine Treatment Sales 2016-2021 (K Dose)
Figure 32. Middle East & Africa Tuberculosis Vaccine Treatment Revenue 2016-2021 ($ Millions)
Figure 33. Americas Tuberculosis Vaccine Treatment Sales Market Share by Country in 2020
Figure 34. Americas Tuberculosis Vaccine Treatment Revenue Market Share by Country in 2020
Figure 35. Americas Tuberculosis Vaccine Treatment Sales Market Share by Type in 2020
Figure 36. Americas Tuberculosis Vaccine Treatment Sales Market Share by Application in 2020
Figure 37. United States Tuberculosis Vaccine Treatment Revenue Growth 2016-2021 ($ Millions)
Figure 38. Canada Tuberculosis Vaccine Treatment Revenue Growth 2016-2021 ($ Millions)
Figure 39. Mexico Tuberculosis Vaccine Treatment Revenue Growth 2016-2021 ($ Millions)
Figure 40. Brazil Tuberculosis Vaccine Treatment Revenue Growth 2016-2021 ($ Millions)
Figure 41. APAC Tuberculosis Vaccine Treatment Sales Market Share by Region in 2020
Figure 42. APAC Tuberculosis Vaccine Treatment Revenue Market Share by Regions in 2020
Figure 43. APAC Tuberculosis Vaccine Treatment Sales Market Share by Type in 2020
Figure 44. APAC Tuberculosis Vaccine Treatment Sales Market Share by Application in 2020
Figure 45. China Tuberculosis Vaccine Treatment Revenue Growth 2016-2021 ($ Millions)
Figure 46. Japan Tuberculosis Vaccine Treatment Revenue Growth 2016-2021 ($ Millions)
Figure 47. Korea Tuberculosis Vaccine Treatment Revenue Growth 2016-2021 ($ Millions)
Figure 48. Southeast Asia Tuberculosis Vaccine Treatment Revenue Growth 2016-2021 ($ Millions)
Figure 49. India Tuberculosis Vaccine Treatment Revenue Growth 2016-2021 ($ Millions)
Figure 50. Australia Tuberculosis Vaccine Treatment Revenue Growth 2016-2021 ($ Millions)
Figure 51. Europe Tuberculosis Vaccine Treatment Sales Market Share by Country in 2020
Figure 52. Europe Tuberculosis Vaccine Treatment Revenue Market Share by Country in 2020
Figure 53. Europe Tuberculosis Vaccine Treatment Sales Market Share by Type in 2020
Figure 54. Europe Tuberculosis Vaccine Treatment Sales Market Share by Application in 2020
Figure 55. Germany Tuberculosis Vaccine Treatment Revenue Growth 2016-2021 ($ Millions)
Figure 56. France Tuberculosis Vaccine Treatment Revenue Growth 2016-2021 ($ Millions)
Figure 57. UK Tuberculosis Vaccine Treatment Revenue Growth 2016-2021 ($ Millions)
Figure 58. Italy Tuberculosis Vaccine Treatment Revenue Growth 2016-2021 ($ Millions)
Figure 59. Russia Tuberculosis Vaccine Treatment Revenue Growth 2016-2021 ($ Millions)
Figure 60. Middle East & Africa Tuberculosis Vaccine Treatment Sales Market Share by Country in 2020
Figure 61. Middle East & Africa Tuberculosis Vaccine Treatment Revenue Market Share by Country in 2020
Figure 62. Middle East & Africa Tuberculosis Vaccine Treatment Sales Market Share by Type in 2020
Figure 63. Middle East & Africa Tuberculosis Vaccine Treatment Sales Market Share by Application in 2020
Figure 64. Egypt Tuberculosis Vaccine Treatment Revenue Growth 2016-2021 ($ Millions)
Figure 65. South Africa Tuberculosis Vaccine Treatment Revenue Growth 2016-2021 ($ Millions)
Figure 66. Israel Tuberculosis Vaccine Treatment Revenue Growth 2016-2021 ($ Millions)
Figure 67. Turkey Tuberculosis Vaccine Treatment Revenue Growth 2016-2021 ($ Millions)
Figure 68. GCC Country Tuberculosis Vaccine Treatment Revenue Growth 2016-2021 ($ Millions)
Figure 69. Channels of Distribution
Figure 70. Distributors Profiles
